Interojo

119610 · KOSDAQ · Health Care · SMALL CAP

Provisional Q1 2026 results.

Interojo filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$21.1M (+32.8% year on year), operating profit of US$4.28M (+185.9% year on year) and net income of US$3.41M (+252.4% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-05-07· RCEPT 20260507900334

US$21.1MRevenue
+32.8%Revenue vs a year earlier
US$4.28MOperating profit

Converted at 1 USD ≈ ₩1,454.79 (filing-date rate, 2026-05-07 close)

What happened

Interojo filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$21.1M (+32.8% year on year), operating profit of US$4.28M (+185.9% year on year) and net income of US$3.41M (+252.4% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$21.1M
Revenue vs a year earlier+32.8%
Operating profitUS$4.28M
Net incomeUS$3.41M
PeriodQ1 2026 (consolidated)
Filed2026-05-07, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260507900334 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-07 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.